Weight Management

Liraglutide

Online intake — Additional evaluation may be required

Liraglutide is a GLP-1 receptor agonist. Saxenda and Victoza are liraglutide brands with different labeling.

Liraglutide — illustrative medication packaging concept
Illustrative concept—not actual dispensed packaging.
GLP-1 receptor agonist
Daily subcutaneous injection
Saxenda and Victoza brand distinctions
Prescription required

What Is Liraglutide?

Saxenda has an FDA-approved chronic weight-management indication for specified populations. Victoza has type 2 diabetes labeling. Their doses and instructions differ; they are not substitutes for each other without a prescription review.

How OakMD Works

OakMD is a telemedicine platform connecting eligible adults with licensed providers. If you're interested in Liraglutide, the process begins with a brief online intake form. A licensed provider will review your health history, symptoms, and goals — and determine if treatment is appropriate for you.

A prescription is not guaranteed. Additional records, testing, a live visit, or in-person care may be required before a prescribing decision.

Frequently Asked Questions

Common Questions

How does the schedule differ from injectable semaglutide?

Liraglutide injections use a daily schedule, while injectable semaglutide products may use a different schedule. These are administration differences, not instructions to switch products. Follow the prescribed product's label.

What warnings require discussion before a prescription?

Semaglutide, tirzepatide, and liraglutide products carry a boxed warning about thyroid C-cell tumors observed in rodents; the relevance to humans is unknown. They are contraindicated with a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN2), or serious hypersensitivity to the prescribed product.

What other risks should I review with a clinician?

Risks include nausea, vomiting, diarrhea, constipation, severe gastrointestinal reactions, pancreatitis, gallbladder disease, kidney injury related to dehydration, and serious allergic reactions. Hypoglycemia risk increases with insulin or sulfonylureas. Discuss gastroparesis, diabetic eye disease, pregnancy plans, and all medicines. These products are not recommended with severe gastroparesis. Tell procedural teams about use before anesthesia or deep sedation because pulmonary aspiration has been reported. Seek urgent care for severe persistent abdominal pain, breathing difficulty, or swelling of the face or throat.

How do brand-name and compounded products differ?

FDA approval applies to the specific approved product and its labeling, not to every preparation containing that ingredient. Compounded drugs are not FDA-approved; the FDA does not review them for safety, effectiveness, or quality before marketing. A compounded preparation is not an FDA-approved generic of a brand-name product.

Ready to Get Started?

Complete a brief online intake. A licensed provider will review your information and determine if treatment is appropriate for you.

The information provided through the OakMD® website, assessments, product pages, checkout flows, communications, and related services is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer: The information provided through the OakMD® website, assessments, product pages, checkout flows, communications, and related services is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Prescription treatment, if any, is provided only after review by a US-licensed provider and only if clinically appropriate. Read the full Medical Disclaimer.